MedPlus Health Services subsidiary, Optival Health Solutions Private Limited, faced a minor operational disruption in Karnataka. A store located at Bidadi Bus Stand received a two-day suspension order for its Drug License. The suspension was based on alleged violations under the Drugs and Cosmetics Act. The company estimates a quantifiable potential revenue loss from this incident, amounting to approximately Rs 2.88 lacs.
Operational Update on Subsidiary Action
MedPlus Health Services Limited has issued a disclosure regarding an order received by its subsidiary, Optival Health Solutions Private Limited. The order pertains to the suspension of a Drug License for one of its retail outlets operating in the state of Karnataka.
Details of the Suspension Order
The suspension order, which was officially received on March 14, 2026, mandates a temporary halt of operations for a duration of two days. The affected store is located at the Bidadi Bus stand, Ramanagar, Karnataka.
Alleged Violations and Financial Impact
The directive for suspension was issued under the provisions of the Drugs and Cosmetics Act, 1940, and associated Rules. The company identified the action as a potential violation or contravention. Consequently, the estimated quantifiable financial impact on the entity’s operations due to this two-day stoppage is calculated at a potential revenue loss of Rs 2.88 lacs.
Company Compliance Statement
The management confirmed that this information is being provided in compliance with regulatory requirements following the receipt of the order. The details are being made public for the benefit of investors and stakeholders.
Source: BSE
